Indication · Cardiology
Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
62
Cleared or approved since 2000
PMA and De Novo
12
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
32
131 device trials in all
Devices
12 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Impella RP System
Abiomed, Inc. · PMA · Temporary Non-Roller Type Right Heart Support Blood Pump · newest 2025 · 14 decisions
11 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Safety and Efficacy of Synchronized Cardiac Support (SCS) Versus Continuous Flow VA-ECMO in Cardiogenic ShockNot yet recruiting
Xenios AGNot on our public-company list
NCT05106491 · 50 participants (planned) · Start Jan 2027 · Primary completion Jan 2029
Device: Synchronized Cardiac Support with the Novalung ultimate kit SCS; Control group: VA-ECMO · For: Cardiogenic Shock; Extracorporeal Membrane Oxygenation; ECLS and 1 more
Sites: Prague, Czechia; Essen, Germany; Madrid, Spain · 4 sites in all
130 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Balloon, Intra-Aortic And Control (DSP)35
- Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)7
- Blood Pump For Ecmo, Long-Term (> 6 Hours) Use (QNR)7
- Temporary Non-Roller Type Right Heart Support Blood Pump (PYX)5
- Dual Lumen Ecmo Cannula (PZS)4
- Oxygenator, Long Term Support Greater Than 6 Hours (BYS)2
- Single Lumen Ecmo Cannula (QHW)1
- Tubing, Long Term Support Greater Than 6 Hours (QWF)1
Research
- Device studies on cardiogenic shock across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.